MCP AbD Serotec
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on October 1, 2006.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
R600008-MCP200v1
5/10/1819    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azad, N. S.
Right arrow Articles by Kohn, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azad, N. S.
Right arrow Articles by Kohn, E. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on May 12, 2006
Accepted on May 30, 2006

Proteomics in clinical trials and practice: present uses and future promise

Nilofer S. Azad, Nabila Rasool, Christina M. Annunziata, Lori Minasian, Gordon Whitely, and Elise C. Kohn

Medical Oncology Branch, National Cancer Institute, Bethesda, MD 20892

Corresponding Author: azadn{at}mail.nih.gov

The proteome consists of all of the protein products that are derived from an individual’s full genetic code. Proteomics bridges the gap between what is encoded in the genome and its translation into proteins. Proteins, rmore than genes, represent the functional output of a cell. Proteomics offers more complexity but potentially more specificity than examining genes alone. The study of proteomics can generally be divided into two categories: 1) the characterization of protein expression and 2) the characterization of protein function. This review details the techniques and possible clinical applications thus far of both expression and functional proteomics.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
U. Kruse, M. Bantscheff, G. Drewes, and C. Hopf
Chemical and Pathway Proteomics: Powerful Tools for Oncology Drug Discovery and Personalized Health Care
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1887 - 1901.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.